PLoS Neglected Tropical Diseases (Jun 2017)

Deltamethrin resistance in Aedes aegypti results in treatment failure in Merida, Mexico.

  • Gonzalo M Vazquez-Prokopec,
  • Anuar Medina-Barreiro,
  • Azael Che-Mendoza,
  • Felipe Dzul-Manzanilla,
  • Fabian Correa-Morales,
  • Guillermo Guillermo-May,
  • Wilbert Bibiano-Marín,
  • Valentín Uc-Puc,
  • Eduardo Geded-Moreno,
  • José Vadillo-Sánchez,
  • Jorge Palacio-Vargas,
  • Scott A Ritchie,
  • Audrey Lenhart,
  • Pablo Manrique-Saide

DOI
https://doi.org/10.1371/journal.pntd.0005656
Journal volume & issue
Vol. 11, no. 6
p. e0005656

Abstract

Read online

The operational impact of deltamethrin resistance on the efficacy of indoor insecticide applications to control Aedes aegypti was evaluated in Merida, Mexico. A randomized controlled trial quantified the efficacy of indoor residual spraying (IRS) against adult Ae. aegypti in houses treated with either deltamethrin (to which local Ae. aegypti expressed a high degree of resistance) or bendiocarb (to which local Ae. aegypti were fully susceptible) as compared to untreated control houses. All adult Ae. aegypti infestation indices during 3 months post-spraying were significantly lower in houses treated with bendiocarb compared to untreated houses (odds ratio <0.75; incidence rate ratio < 0.65) whereas no statistically significant difference was detected between the untreated and the deltamethrin-treated houses. On average, bendiocarb spraying reduced Ae. aegypti abundance by 60% during a 3-month period. Results demonstrate that vector control efficacy can be significantly compromised when the insecticide resistance status of Ae. aegypti populations is not taken into consideration.